News | Cardiovascular Surgery
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research presented at Heart Failure 2017 and the 4th World Congress on Acute Heart Failure, April 29-May 2 in Paris, France. The breakthrough came on the 50th anniversary of heart transplantation.
May 23, 2017
Case Study | Cardiovascular Information Systems (CVIS)
Located along Mississippi’s Gulf Coast, Memorial Hospital at Gulfport is a nonprofit, 445-bed facility originally ...
May 23, 2017
Videos | Pacemakers
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospital ...
May 23, 2017Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
This video, provided by ERB, demonstrates the function and implantation of the WiSE CRT (Wireless Stimulation ...
May 23, 2017News | Heart Failure
Serelaxin failed to meet the primary endpoints of the phase 3 RELAX-AHF-2 trial, according to late-breaking results presented at Heart Failure 2017 and the 4th World Congress on Acute Heart Failure, April 29-May 2 in Paris, France.
May 22, 2017
News | Mobile Devices
May 22, 2017 — Consumers are being warned about the accuracy of heart rate apps after a study found huge variability ...
May 22, 2017Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced the signing of a definitive license agreement for the continued Phase III development and worldwide commercialization of flurpiridaz F-18. Flurpiridaz F-18 is an investigational positron emission tomography (PET) myocardial perfusion imaging (MPI) agent that may improve the diagnosis of coronary artery disease (CAD), the most common form of heart disease. The definitive agreement follows the signing of a term sheet previously announced in late February 2017.
May 22, 2017
News | Balloon Catheter
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports of ...
May 22, 2017
News | Cath Lab
May 19, 2017 — TherOx Inc. announced that it completed enrollment in the IC-HOT (Evaluation of Intracoronary Hyperoxemic ...
May 19, 2017Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Heart Valve Technology
Nearly one-quarter of patients with a mechanical heart valve say it disturbs their sleep, according to research presented at EuroHeartCare 2017, May 18-20 in Jonkoping, Sweden.
May 19, 2017
Videos | Atrial Fibrillation
Hugh Calkins, M.D., FACC, FAHA, FHRS, director of cardiac arrhythmia services and professor of medicine at Johns Hopkins ...
May 17, 2017
May 12, 2017 – Results from the U.S. post-market approval study evaluating “real-world” patients implanted with the ...
May 17, 2017Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Videos | EP Lab
This video, provided by Spectranetics, demonstrates how to deploy the Bridge Occlusion Balloon used to seal accidental ...
May 17, 2017
Feature | Dave Fornell
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigational ...
May 17, 2017
Feature | EP Lab | Dave Fornell
May 17, 2017 — A new intravenous occlusion balloon designed to seal any accidental tears in the superior vena cava (SVC) ...
May 17, 2017© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now